The historical rank and industry rank for Guided Therapeutics's Net Margin % or its related term are showing as below:
GTHP'
s Net Margin % Range Over the Past 10 Years
Min: -33392.31 Med: -1878.21 Max: 1782.46
Current: -3560.2
GTHP's Net Margin % is ranked worse than 95.95% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.49
vs GTHP: -3560.20
Guided Therapeutics Net Margin % Historical Data
The historical data trend for Guided Therapeutics's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Guided Therapeutics's Net Margin %
For the Medical Devices subindustry, Guided Therapeutics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guided Therapeutics's Net Margin % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Guided Therapeutics's Net Margin % distribution charts can be found below:
* The bar in red indicates where Guided Therapeutics's Net Margin % falls into.
Guided Therapeutics Net Margin % Calculation
Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.
Guided Therapeutics's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guided Therapeutics (OTCPK:GTHP) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Guided Therapeutics Net Margin % Related Terms
Thank you for viewing the detailed overview of Guided Therapeutics's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Guided Therapeutics (Guided Therapeutics) Business Description
Guided Therapeutics Inc is a medical technology company. It is engaged in developing medical devices that have the potential to improve healthcare. Its primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device and extension of its cancer detection technology into other cancers, including esophageal. The company generates revenue from the sale of medical devices.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
GTHP has been successfully added to your 